Physician profile

Vasantha K Hathwar

Pulmonary Disease · Virginia Beach, VA

NPI 1669572608

$12,812.93

in general payments reported to CMS, 2019-2025

51 companies · $1,998 in 2025

The $1,998 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,720.89
Education$353.24

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $1,921.67 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Astrazeneca Pharmaceuticals LP $1,502.98 2019-2025 Fasenra, Breztri, Airsupra
Intuitive Surgical, INC. $960.78 2022
Boehringer Ingelheim Pharmaceuticals, INC. $794.47 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Actelion Pharmaceuticals US, INC. $742.01 2019-2025 Uptravi, Opsumit, Opsynvi
Mallinckrodt Hospital Products INC. $550.43 2020-2025 Acthar
Genzyme Corporation $424.03 2019-2025
Takeda Pharmaceuticals U.S.A., INC. $387.97 2020-2025 Glassia, Cuvitru
Amgen INC. $384.77 2022-2025 Tezspire, Tavneos
Jazz Pharmaceuticals INC. $363.03 2019-2025
Ani Pharmaceuticals, INC. $352.35 2022-2025 Purified Cortrophin Gel
Sunovion Pharmaceuticals INC. $340.61 2019-2021
Grifols USA, LLC $292.27 2019-2024 Prolastin-C Liquid
Merck Sharp & Dohme LLC $282.80 2019-2025 Winrevair, Zerbaxa, Recarbrio
Genentech USA, INC. $252.98 2019-2023 Xolair
Show all 51 companies
CompanyGeneral paymentsYearsTop products
Regeneron Healthcare Solutions, INC. $243.34 2019-2025 Dupixent
Novartis Pharmaceuticals Corporation $217.41 2019-2025
Philips North America LLC $187.88 2019-2025 Incourage Airway Clearance Therapy, (Ak6) Vest Therapy, Vest Therapy Und
Mallinckrodt Enterprises LLC $179.04 2019
Verona Pharma, INC. $169.89 2025 Ohtuvayre
Baxter Healthcare $167.71 2022-2024 Hillrom - Vest System Model 105 Home Care
Harmony Biosciences LLC $158.31 2020-2025 Wakix
Insmed, INC. $155.75 2019-2025 Arikayce
Paratek Pharmaceuticals, INC. $152.01 2021-2023 Nuzyra
Janssen Pharmaceuticals, INC $142.11 2019-2024 Xarelto
Axsome Therapeutics, INC. $140.71 2023-2025 Sunosi
United Therapeutics Corporation $135.05 2022-2025 Tyvaso, Tyvaso
Pfizer INC. $120.17 2019-2024
Pharming Healthcare, INC. $117.68 2022-2023 Ruconest
Avadel Cns Pharmaceuticals, LLC $112.77 2023-2025 Lumryz
Mylan Specialty L.P. $105.69 2019-2024 Yupelri
Sanofi-Aventis U.S. LLC $99.95 2025
Advanced Respiratory, INC $96.66 2019-2021
Inspire Medical Systems, INC. $89.85 2023-2025 Inspire
Resmed Corp $48.59 2019-2020
Bayer Healthcare Pharmaceuticals INC. $47.55 2019-2022
Gilead Sciences, INC. $42.23 2019
Teva Pharmaceuticals USA, INC. $36.68 2021-2022
Idorsia Pharmaceuticals US INC $33.44 2023 Quviviq
Arbor Pharmaceuticals, INC. $31.31 2019
Electromed, INC. $29.74 2019-2024 Smartvest
Inari Medical, INC. $26.04 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Vifor Pharma, INC. $25.38 2024 Zemaira
Shionogi INC $24.03 2024 Fetroja
Nabriva Therapeutics, Plc $20.72 2021
Phadia US INC. $19.59 2024 Immunocap
Pulmonx Corporation $19.53 2023 Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter
Shire North American Group INC $18.73 2019
Viatris Specialty LLC $17.32 2025 Yupelri
Boston Scientific Corporation $15.94 2019
Circassia INC. $10.98 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Vasantha K Hathwar

$12,812.93

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $1,998 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/29941/vasantha-k-hathwar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.